A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE Trial. - Terashima T; Ikeda M; Yamashita T; Okusaka T; Imaoka H; Kawaoka T; Kobayashi S; Ogasawara S; Hiraoka A; Nakano M; Okano N; Sugimoto R; et al. (Liver cancer, 2026)